|
Briefing
|
- Diabetic Blindness Screening AI – Google and healthcare unit Verily developed machine learning algorithm that can screen people for diabetic eye disease, such as diabetic retinopathy (DR) and diabetic macular edema (DME)
- How It Works – Patient is imaged using fundus camera, a low-power microscope with attached camera, with image uploaded to algorithm, which then screens patient for DR and DME
- Deployment – AI deployed in Aravind Eye Hospital in Madurai, India as its first real world clinical use case
- Benefits – Early detection can prevent blindness, with AI giving doctors more time to treat the disease, while increasing volume of screenings performed
- EU-Certified – Algorithm received European Union certification for meeting medical device standards
- Expansion – Has expanded research efforts in Rajavithi Hospital in Thailand in late 2018, and will broaden reach worldwide in 2019
|
|
Accelerator
|
|
|
Sector
|
Healthcare/Health Sciences
|
|
Organization
|
Alphabet Inc., Google Inc., Verily Life Sciences LLC
|
|
Source
|
|
|
Original Publication Date
|
February 25, 2019
|
